Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia

• 1. 化合物SS‑31在制备治疗弗里德赖希共济失调及相关疾病药物中的应用 [P] . 中国专利： CN107320711A . 2017-11-07
• 2. 肌肉靶向复合物及其用于治疗弗里德赖希共济失调的用途 [P] . 中国专利： CN113166240A . 2021-07-23
• 3. Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia [P] . 美国专利： US10337027B2 . 2019-07-02

  机译： 治疗和预防因弗里德里希共济失调引起的心肌病的方法和药物组合物

• 4. METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO FRIEDREICH ATAXIA [P] . 美国专利： US2015313969A1 . 2015-11-05

  机译： 方法和药物成分用于治疗和预防因腓肠肌引起的心肌病

• 5. METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CARDIOMYOPATHY DUE TO FRIEDREICH ATAXIA [P] . 美国专利： US2014221462A1 . 2014-08-07

  机译： 方法治疗药物性脂肪性心律失常的方法和药物组合物

• 1. Preclinical Evaluation of Pharmaceutical Compositions and Their Components for Urinary Health [J] . Francesco De Seta, Jonathan Wayne Lowery, Oladipupo Ogunbekun OMS II, 妇产科期刊（英文） . 2020,第001期
• 2. Rationale for clinical trials of selenium as an antioxidant for the treatment of the cardiomyopathy of Friedreich's ataxia. [J] . Fryer MJ Medical hypotheses . 2002,第2期
• 3. An unusual combination of large Eustachian valve in a young patient with Friedreich’s ataxia cardiomyopathy [J] . Stylianos A. Karvounaris, Georgios S. Papaetis, Petros P. Mavrommatis Cardiology Journal . 2021,第3期
• 4. Cardiomyopathy as the first manifestation of Friedreich's ataxia [J] . Rafael Tuzino Leite Neves Maffei, Giulio de los Santos Fortuna, Luca Campolino Rosso, Autopsy & case reports. . 2020,第3期
• 5. mm-wave dielectrometry methods for prediction, prevention, diagnostics and individual treatment at acute cardiac infarction and cardiomyopathy [C] . Altuchov, A.L., Vasilieva, . 2001
• 6. Analytical methods validation and bench scale UV treatment of pharmaceutical compounds and contrast media in water. [D] . Pereira, Vanessa Ranhada Pinto Jorge. 2005
• 7. Reverse Phase Protein Array Reveals Correlation of Retinoic Acid Metabolism With Cardiomyopathy in Friedreichs Ataxia [O] . Jill S. Napierala, Kimal Rajapakshe, Amanda Clark, 2021
• 8. Plasma Lipids and Lipoproteins in Friedreich's Ataxia and Familial Spastic Ataxia — Evidence for an Abnormal Composition of High Density Lipoproteins [O] . Y. S. Huang, A. C. Nestruck, A. Barbeau, 1978
• 9. Pharmaceutical Compositions and Methods to Vaccinate Against Disseminated Candidiasis. [R] . Edwards, J. E., Filler, S. G., Sheppard, D. C., 2005

• 1. Clinical and Genetic Study of Friedreich’s Ataxia and Ataxia with Vitamin E Deficiency in 44 Moroccan Families [J] . Fatima Imounan ,Naima Bouslam ,El Hachmia Aitbenhaddou . 神经科学国际期刊（英文） . 2014,第4期
• 2. Heart disease in Friedreich's ataxia [J] . Emily Hanson ,Mark Sheldon ,Brenda Pacheco . 世界心脏病学杂志：英文版（电子版） . 2019,第1期
• 3. Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases [J] . Annita Kolnagou ,Christina N Kontoghiorghe ,George J Kontoghiorghes . 世界方法学杂志 . 2014,第4期
• 4. Numerical Treatment of Initial Value Problems of Nonlinear Ordinary Differential Equations by Duan-Rach-Wazwaz Modified Adomian Decomposition Method [J] . Omür Umut ,Serpil Yasar . 现代非线性理论与应用（英文） . 2019,第1期
• 5. 头孢吡肟对产ESBL大肠埃希菌所致急性细菌性感染的治疗作用观察 [C] . 刘焱斌 ,俞汝佳 ,付学勤 . 第十一次全国临床药理学学术大会 . 2008
• 6. 原发性肉碱缺乏症所致心肌病的临床表现、基因突变分析及治疗随访研究 [A] . 刘晓亮 . 2016